Detalhe da pesquisa
1.
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
Lung Cancer
; 113: 79-84, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29110854
2.
Fluoxetine alleviates behavioral depression while decreasing acetylcholine release in the nucleus accumbens shell.
Neuropsychopharmacology
; 36(8): 1729-37, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21525864